Associated Papers
CARMIL2 deficiency disrupts activation-induced metabolic reprogramming in T cells and is partially rescued by glutamine supplementation.
Kabha M et al.
The Journal of Allergy and Clinical Immunology, 2025
Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
Shamriz O et al.
Clinical and Experimental Immunology, 2020
Select a paper to view details